Imexpharm Corporation (HOSE:IMP)
53,600
-900 (-1.65%)
At close: Jan 20, 2026
Imexpharm Market Cap
Imexpharm has a market cap or net worth of 8.25 trillion as of January 20, 2026. Its market cap has increased by 13.44% in one year.
Market Cap
8.25T
Enterprise Value
8.23T
Revenue
2.45T
Ranking
n/a
PE Ratio
24.78
Stock Price
53,600.00
Market Cap Chart
Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 8.25T, an increase of 644.49%. That is a compound annual growth rate of 11.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 8.39T | 3.81% |
| Dec 31, 2025 | 8.09T | 11.70% |
| Dec 31, 2024 | 7.24T | 82.69% |
| Dec 29, 2023 | 3.96T | -1.28% |
| Dec 30, 2022 | 4.01T | -22.62% |
| Dec 31, 2021 | 5.19T | 38.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition